Welcome to OPTIMA, a patient driven clinical study for people with hormone sensitive early breast cancer.
OPTIMA aims to improve the way we make decisions about whom we offer chemotherapy to following surgery.
The study is now recruiting in the UK, Norway, Sweden, Australia, New Zealand and Thailand.